[(123)I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer. Chan CY, Chen Z, Guibbal F, Dias G, et al. J Nucl Med 2023 Sep 28:jnumed.123.265429. doi: 10.2967/jnumed.123.265429.

Read + Share

Amedeo Smart

Independent Medical Education

Chan CY, Chen Z, Guibbal F, Dias G, et al. [(123)I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer. J Nucl Med 2023 Sep 28:jnumed.123.265429. doi: 10.2967/jnumed.123.265429.
PMID: 37770109